FDA Announces Recall of Hypertension Drug Due To Possible Contamination

A recall has been announced of a hypertension drug due to the possibility that shipments may have been contaminated with a different drug.

What's been recalled?

Glenmark Pharmaceuticals announced the recall for multiple lots of bisoprolol fumarate and hydrochlorothiazide tablets, better known by the brand name Ziac.

The recall was initiated after testing of samples indicated that the pills, which were manufactured in India, were potentially contaminated with a cholesterol medication made at the same facility.

The FDA has labelled this a Class III risk, which means they don't consider continuing to use the recalled product likely to cause adverse health complications.  So there's a bit of good news that will hopefully calm anyone taking these drugs just a little.

However, just because the FDA thinks it isn't likely doesn't mean it can't or won't happen.  It's still good advice to check your prescription against the lots listed below.  If yours matches, talk to your doctor and/or pharmacist about getting a new batch and stop using the recalled drugs as soon as they've been replaced.

What am I looking for?

The lots in question cover dosage strengths ranging from 2.5 to 6.25 mg.

• 30-tablet bottles, NDC-68462-878-30. Lot 17232401, exp. 11/2025.
• 100-tablet bottles, NDC-68462-878-01. Lot 17232401, exp. 11/2025.
• 500-tablet bottles, NDC-68462-878-05. Lots 17232401, exp. 11/2025 and 17240974, exp. 05/2026

For more information, you can also go here and search for Event ID 98036.